Aug. 24, 2023
DOD-Supported Lifesaving Autoinjector to Combat Ultra-Potent Opioid Exposure Available through DLA
FORT DETRICK, MD —
Logistics In Action: Article originally appeared on the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense website — Tasked with delivering a lifesaving pharmaceutical to service members who may be exposed to ultra-potent opioids, the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical’s Rapid Opioid Countermeasure System program helped develop and deliver a high-dose naloxone autoinjector as a rescue treatment to counter opioid poisoning in less than three years.